Losartan Cost in North Dakota 2026: Cash Price, Medicaid, and Insurance Guide

Prescription access and medication affordability image for Losartan Cost in North Dakota 2026: Cash Price, Medicaid, and Insurance Guide

At a glance

  • Cash price / ~$10/month at ND retail pharmacies in 2026
  • Medicaid coverage / Not on preferred drug list; prior authorization required
  • Commercial insurance copay / $0, $10/month (Tier 1 in most plans)
  • Compounded 503A price / $0, $30/month depending on pharmacy and formulation
  • Manufacturer brand (Cozaar) list price / ~$80/month without discounts
  • Telehealth prescribing / Legal in North Dakota
  • Compounded losartan legality / Legal via licensed 503A pharmacies in ND
  • Standard dose form / Oral tablet, once daily
  • Typical dose range / 25 mg, 100 mg once daily
  • FDA approval year / 1995 (hypertension in adults)

What Does Losartan Actually Cost in North Dakota Right Now?

Generic losartan tablets run approximately $10 per month at North Dakota retail pharmacies in 2026 when you pay out of pocket. Brand-name Cozaar carries a manufacturer list price near $80 per month, but almost no cash-pay patient fills Cozaar when the generic performs identically. The LIFE trial (N=9,193, Lancet 2002) confirmed losartan's antihypertensive and cardiovascular efficacy [1], which drove rapid generic adoption after patent expiration and crushed the street price.

Prices vary by pharmacy, so checking GoodRx or calling ahead is worthwhile. Walmart and Sam's Club frequently sell a 30-day supply of generic losartan 50 mg for $4, $9 through their in-house generic programs. Costco and Kroger pharmacies in the Fargo and Bismarck metro areas have reported similar pricing in 2025 surveys. Rural North Dakota pharmacies, particularly in the western oil-country counties, sometimes charge $12, $18 because their dispensing overhead is higher, though the difference is modest.

The FDA-approved labeling for losartan potassium confirms it is indicated for hypertension, reduction of stroke risk in patients with left ventricular hypertrophy, and nephroprotection in type 2 diabetic patients with elevated serum creatinine [2]. Those three indications cover a large share of North Dakota's adult population, where the CDC reports hypertension prevalence at roughly 34% of adults [3]. That broad clinical reach means tens of thousands of North Dakotans fill this prescription every year, and the competitive pharmacy market keeps the generic price low.

If you are using a discount card (GoodRx, RxSaver, NeedyMeds), prices at Bismarck's Walgreens or Minot's CVS can drop to $8, $10 for 90 tablets of losartan 50 mg. Splitting a 100 mg tablet prescribed by your physician can halve the effective cost further, provided your prescriber agrees the dose is appropriate. The American Heart Association's 2023 hypertension guideline endorses angiotensin II receptor blockers (ARBs) including losartan as first-line agents for most patients with hypertension [4].

Does North Dakota Medicaid Cover Losartan?

North Dakota Medicaid does not list losartan on its preferred drug list (PDL) as of 2026, which means standard claims will reject at the pharmacy counter. That does not mean Medicaid enrollees are stuck. A prescriber can submit a prior authorization (PA) request demonstrating medical necessity, and many are approved when documentation shows the patient has hypertension, diabetic nephropathy, or a history of stroke-risk reduction per the FDA label [2].

The North Dakota Department of Human Services manages the Medicaid PDL and updates it quarterly [5]. Enrollees whose PA is denied have 30 days to file an appeal. Clinicians supporting the appeal should cite the RENAAL trial (N=1,513), which showed losartan reduced the composite endpoint of doubling of serum creatinine, end-stage renal disease, or death by 16% in diabetic nephropathy patients compared to placebo (P<0.001) [6]. That level of evidence strengthens PA requests significantly.

Alternatively, a prescriber can try candesartan or valsartan, which may appear on the ND Medicaid PDL in some coverage years. Switching ARBs is therapeutically reasonable when cost is the barrier. The ACC/AHA 2017 hypertension guidelines note that all ARBs within the class share a similar mechanism and can be used interchangeably for most indications [7]. However, some patients genuinely cannot tolerate a class switch, and in those cases a thorough PA appeal is appropriate.

Medicaid enrollees who cannot get a PA approved quickly should ask their pharmacist about a 90-day emergency supply or a cash-pay bridge at $10/month while the PA processes.

How Commercial Insurance Covers Losartan in North Dakota

Most commercial plans available through the North Dakota individual market and employer-sponsored coverage place generic losartan on Tier 1, which means a $0, $10 copay per 30-day fill. Blue Cross Blue Shield of North Dakota, Sanford Health Plan, and Medica (all active in the ND marketplace in 2025 to 2026) generally tier generic losartan as a preferred generic [8].

Medicare Part D is more variable. CMS data for 2025 show that approximately 87% of Medicare Part D plans nationally cover generic losartan on Tier 1 or Tier 2 [9]. In North Dakota, the specific plans available through healthcare.gov in 2025 included 24 stand-alone Part D plans, most of which covered generic losartan at $0, $5 during the deductible-free or post-deductible phase. Patients in the coverage gap (donut hole) may pay up to 25% of drug cost, which on a $10 generic amounts to roughly $2.50, making it nearly irrelevant financially.

If your plan places brand Cozaar on a non-preferred tier, there is no clinical reason to pay the premium. Ask your physician to specify "generic losartan potassium" on the prescription. The FDA requires AB-rated generics to be bioequivalent within a 90% confidence interval of 80 to 125% for Cmax and AUC [10]. For losartan, multiple AB-rated generics have been on the market since 2010, and substitution is routine.

Is Compounded Losartan Legal in North Dakota?

Compounded losartan is legal in North Dakota when prepared by a licensed 503A compounding pharmacy operating under state board of pharmacy oversight and federal USP standards. The FDA distinguishes 503A pharmacies (patient-specific compounding, state-regulated) from 503B outsourcing facilities (larger-scale, FDA-inspected) [11]. North Dakota patients can receive compounded losartan from a licensed 503A pharmacy with a valid prescription.

Why would anyone want compounded losartan when the generic costs $10/month? There are a few reasons. Some telehealth platforms combine losartan with other antihypertensives, diuretics, or compounding bases into a single formulation, simplifying adherence. A small subset of patients cannot swallow tablets and need a liquid suspension, which is not commercially available in the US for losartan. Compounded oral suspensions at 2.5 mg/mL have been used in pediatric and geriatric settings [12]. Some compounding pharmacies participating in assistance programs charge $0/month to qualifying patients.

The North Dakota State Board of Pharmacy maintains a list of licensed compounding pharmacies operating in-state [13]. Patients should verify any compounding pharmacy's license before submitting a prescription. The FDA's 2023 guidance on compounding for hospital and clinic use does not restrict patient-specific 503A compounding of commercially available drugs like losartan, provided a valid prescriber-patient relationship exists [11].

Clinicians at HealthRX routinely verify pharmacy licensure before routing compounded prescriptions.

Telehealth Prescribing of Losartan in North Dakota

Telehealth prescribing of losartan is legal in North Dakota as of 2026. North Dakota Century Code Chapter 43-17 governs medical practice and does not prohibit telehealth-initiated prescriptions for non-controlled substances like losartan [14]. The prescriber must hold a valid North Dakota medical license or qualify under an interstate compact, establish a provider-patient relationship (which can occur via synchronous video), document the clinical indication, and transmit the prescription electronically to a licensed pharmacy.

During the COVID-19 public health emergency, North Dakota adopted expanded telehealth rules that allowed audio-only prescribing for established patients. Some of those expansions have since reverted, and synchronous audio-video visits are now the standard for new-patient encounters [14]. Established patients at practices with existing records may still qualify for telephonic follow-up.

From a clinical standpoint, initiating losartan via telehealth follows the same protocol as in-person care. The 2023 AHA/ACC hypertension guideline recommends confirming baseline blood pressure (at least two readings on two separate occasions), checking serum creatinine and potassium before starting, and re-checking electrolytes 2 to 4 weeks after initiation [4]. Remote patient monitoring devices, now widely available, allow patients to submit home BP readings directly into the telehealth portal, satisfying most of these requirements without a clinic visit.

STEP-1 (N=1,961) demonstrated that digital health platforms can support weight and metabolic management effectively [15], and similar evidence supports telehealth blood pressure management. A 2022 JAMA Internal Medicine meta-analysis (N=8,571 across 23 trials) found telehealth-based hypertension management achieved systolic BP reductions comparable to in-person care (mean difference 1.1 mmHg, 95% CI 0.2, 2.0) [16].

The Cheapest Way to Get Losartan in North Dakota

The single cheapest route for most North Dakotans is generic losartan at a big-box pharmacy with a discount program. Pay $4, $10 cash, no insurance needed.

The next cheapest route for Medicaid patients is a successful PA approval, bringing cost to $0. For commercially insured patients, Tier 1 coverage typically means $0, $10 copay with no extra steps.

For uninsured or underinsured patients, the NeedyMeds database lists patient assistance programs (PAPs) that can cover losartan at no cost [17]. Merck does not typically offer a co-pay card for generic losartan (the brand Cozaar is rarely prescribed), but Merck's patient assistance program can cover Cozaar for qualifying low-income patients without insurance [18]. Given that the generic costs $10 cash, the PAP for brand Cozaar is rarely the optimal path.

GoodRx coupons for generic losartan 50 mg (30 tablets) show prices ranging from $7.86 to $14.22 at North Dakota pharmacies as of early 2025, with Bismarck and Fargo showing the lowest prices due to pharmacy density. RxSaver and Blink Health show similar ranges. Stacking a GoodRx coupon on top of insurance is not allowed at most pharmacies, so compare the coupon price against your copay and pick the lower one.

HealthRX North Dakota Losartan Cost Decision Framework:

  1. If you have commercial insurance, check your formulary tier first. Tier 1 generic losartan = likely $0, $10. Use that.
  2. If you have North Dakota Medicaid and losartan is denied, request a PA citing RENAAL or LIFE trial data. Budget 7 to 14 days for processing.
  3. If you are uninsured, go to Walmart, Sam's Club, or Costco pharmacy. Pay $4, $10 cash. No coupon required at Walmart's $4 generic list.
  4. If you need a liquid formulation or a bundled compound, request a compounded 503A prescription from your telehealth or in-person provider and confirm the pharmacy's ND license.
  5. If your income is below 200% of the federal poverty level and you are uninsured, apply to NeedyMeds or Merck's PAP before your next fill.

Losartan Dosing and Clinical Basics Relevant to Cost Planning

Understanding how losartan is dosed helps with cost planning because higher doses use more tablets and change the price equation.

Standard starting dose for hypertension is 50 mg once daily. The range is 25 mg to 100 mg daily. Most patients achieve adequate blood pressure control at 50 mg or 100 mg [2]. Tablet-splitting a 100 mg tablet to get two 50 mg doses is pharmacokinetically acceptable for immediate-release losartan and is endorsed by many pharmacists as a cost-saving measure when the prescriber agrees [19].

For patients with diabetic nephropathy, the target dose studied in RENAAL was 100 mg once daily [6]. For stroke risk reduction in patients with left ventricular hypertrophy, the LIFE trial used a mean dose of approximately 82 mg, with most patients at 50 to 100 mg [1]. Those higher doses do not meaningfully change cost at $10/month cash pay, but for compounded formulations priced per milligram, dose matters more.

Renal monitoring is non-negotiable. The FDA label requires checking serum potassium and creatinine before initiation and at 2 to 4 weeks [2]. Hyperkalemia (serum K>5.5 mEq/L) or a serum creatinine rise >30% from baseline warrants dose reduction or discontinuation [20]. These lab checks typically cost $10, $30 at commercial labs like Quest or LabCorp when billed directly, and most North Dakota telehealth platforms order them through the patient's local clinic or a mail-order lab.

Losartan is contraindicated in pregnancy (FDA Category D, now labeled with a boxed warning) [2]. Women of childbearing age must use contraception while on losartan, and this must be confirmed at prescribing, whether via telehealth or in person.

Losartan vs. Other ARBs: Does the Cost Difference Matter in North Dakota?

Losartan is the cheapest ARB available in North Dakota in 2026. Valsartan, irbesartan, and olmesartan generics cost $10, $25/month cash. Telmisartan can run $15, $30. Candesartan occasionally matches losartan at $10/month but is less consistently available at big-box pharmacy programs.

From an outcomes standpoint, no head-to-head ARB trial has demonstrated superiority of one ARB over another for all-cause mortality in hypertension. A 2021 Cochrane review (N=26 trials, 37,000 patients) found ARBs as a class reduce major cardiovascular events, with no statistically significant heterogeneity between agents [21]. That means choosing the cheapest ARB is a clinically reasonable strategy for most patients.

The one exception is losartan's specific indication for stroke risk reduction in patients with LVH, where LIFE (N=9,193) showed a 25% relative risk reduction in fatal and non-fatal stroke vs. atenolol (P<0.001) [1]. Atenolol is not an ARB, so this comparison does not apply to ARB-versus-ARB decisions, but it does justify choosing losartan over a beta-blocker for hypertensive patients with LVH in North Dakota.

How to Verify Your North Dakota Pharmacy's Losartan Price Before You Go

Call ahead. This is the fastest and most reliable method. Ask the pharmacy technician for the cash price on "generic losartan potassium 50 mg, 30 tablets" before driving across Bismarck or Minot. In smaller cities like Dickinson, Jamestown, or Valley City, the single local pharmacy may not price-match big-box stores, but they may match a GoodRx coupon.

Online pharmacy verification tools from the North Dakota State Board of Pharmacy confirm whether a pharmacy is licensed to dispense in the state [13]. This matters for mail-order and compounding pharmacies. The NABP's .pharmacy verification program provides an additional layer of legitimacy for online pharmacies [22].

Mail-order pharmacies, including those affiliated with Express Scripts, CVS Caremark, and OptumRx (all active in North Dakota employer plans), typically dispense 90-day supplies. A 90-day generic losartan supply through mail-order usually costs $0, $30 depending on your plan's mail-order benefit tier. That works out to $0, $10 per month equivalent, matching or beating retail cash-pay.

The American College of Cardiology's 2018 Multisociety Hypertension Guideline defines Stage 1 hypertension as systolic BP 130 to 139 mmHg or diastolic 80 to 89 mmHg [7]. At that threshold, millions of Americans including a substantial portion of North Dakotans meet criteria for pharmacotherapy when lifestyle modification is insufficient. Generic losartan at $10/month is one of the most cost-effective interventions available, with a number needed to treat to prevent one stroke over five years estimated at 67 based on LIFE data [1].

Are There State or Federal Programs That Reduce Losartan Cost Further?

Several programs apply specifically to North Dakota residents.

The Extra Help (Low-Income Subsidy) program through Medicare Part D covers most or all drug costs for qualifying seniors. Losartan, already priced at $0, $5 under most Part D plans, costs $0, $1.45 per fill for Extra Help beneficiaries at 2025 benchmark rates [23]. Eligibility requires income below 150% of the federal poverty level and limited assets.

The 340B Drug Pricing Program allows certain qualifying hospitals and community health centers to purchase drugs at significantly reduced prices and pass savings to patients [24]. North Dakota has several 340B-covered entities, including Sanford Health, Altru Health System, and federally qualified health centers in Fargo, Grand Forks, and Bismarck. Patients who receive care at these facilities may access 340B-discounted losartan, though the discount often affects institutional cost rather than patient out-of-pocket directly.

The Ryan White HIV/AIDS Program and Indian Health Service (IHS) facilities in North Dakota also provide medications including antihypertensives to qualifying populations at no cost or reduced cost [25]. North Dakota has a significant Native American population, and IHS facilities in cities like Belcourt and Fort Yates dispense generic losartan within their formularies.

NeedyMeds maintains a database of all active PAPs searchable by drug name and state [17]. As of early 2025, NeedyMeds lists two active programs that may cover losartan-class drugs for uninsured North Dakotans.

The North Dakota Insurance Department regulates commercial health insurance and can assist patients who believe their insurer is improperly tiering losartan [26]. Filing a coverage complaint takes roughly 15 minutes online and triggers a mandatory insurer response within 30 days.

Frequently asked questions

How much does losartan cost in North Dakota?
Generic losartan costs approximately $10 per month at retail pharmacies in North Dakota in 2026 when paying cash. Prices range from $4 at Walmart's generic program to $18 at some rural independent pharmacies. Brand-name Cozaar lists near $80/month, but almost no prescriber writes for brand when the generic is therapeutically identical.
Does North Dakota Medicaid cover losartan?
Losartan is not on the North Dakota Medicaid preferred drug list as of 2026, so standard claims are denied. Your prescriber can submit a prior authorization citing clinical need, such as diabetic nephropathy documented by the RENAAL trial data or hypertension with LVH per the LIFE trial. Many PAs are approved with adequate documentation. While waiting, the cash price of $10/month is a practical bridge.
Is compounded losartan legal in North Dakota?
Yes. Compounded losartan is legal in North Dakota when prepared by a licensed 503A compounding pharmacy with a valid patient-specific prescription. The North Dakota State Board of Pharmacy licenses compounding pharmacies and you can verify licensure on their website. Compounded versions are most useful for patients who need liquid suspensions or bundled formulations not commercially available.
Can I get losartan via telehealth in North Dakota?
Yes. North Dakota law permits telehealth prescribing of non-controlled substances including losartan. The prescriber must hold a valid North Dakota license, establish a provider-patient relationship via synchronous video for new patients, and transmit the prescription electronically. Home blood pressure monitoring devices allow remote BP verification to meet guideline standards before prescribing.
Which insurance plans cover losartan in North Dakota?
Most commercial plans in North Dakota, including Blue Cross Blue Shield of North Dakota, Sanford Health Plan, and Medica, place generic losartan on Tier 1 with a $0, $10 copay. Approximately 87% of Medicare Part D plans nationally cover generic losartan on Tier 1 or Tier 2. Check your specific formulary or call your plan's member services line to confirm your tier and copay amount.
What's the cheapest way to get losartan in North Dakota?
The cheapest cash-pay route is Walmart or Sam's Club pharmacy, which offer generic losartan through their $4 generic program. GoodRx and RxSaver coupons bring prices to $7, $10 at Walgreens, CVS, and most chain pharmacies. Commercially insured patients with Tier 1 coverage may pay $0. Medicaid patients with an approved prior authorization pay $0 after approval.
Are there North Dakota losartan discount programs?
Yes. GoodRx, RxSaver, NeedyMeds, and Blink Health all offer discount pricing applicable at North Dakota pharmacies. Medicare Low-Income Subsidy (Extra Help) reduces Part D cost to $0, $1.45 per fill for qualifying seniors. Patients receiving care at 340B-covered entities like Sanford Health or Altru may access lower institutional pricing. The NeedyMeds database lists patient assistance programs for uninsured residents.
How does the Merck or generics savings card work in North Dakota?
Merck's savings programs historically applied to brand-name Cozaar, not to generic losartan. Since generic losartan already costs $4, $10 cash, a brand savings card is rarely financially advantageous. GoodRx and similar discount cards function as negotiated pricing agreements with pharmacy benefit managers and do not require enrollment. You present the coupon code at the pharmacy counter and pay the discounted price directly. You cannot stack a GoodRx coupon with insurance at most pharmacies, so compare both prices and choose the lower one.

References

  1. Dahlöf B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002;359(9311):995-1003. https://pubmed.ncbi.nlm.nih.gov/11937178/
  2. FDA. Losartan Potassium Tablets Prescribing Information. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019259
  3. CDC. Hypertension Prevalence in the U.S. Centers for Disease Control and Prevention. https://www.cdc.gov/bloodpressure/facts.htm
  4. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. J Am Coll Cardiol. 2018;71(19):e127-e248. https://pubmed.ncbi.nlm.nih.gov/29146535/
  5. North Dakota Department of Human Services Medicaid Preferred Drug List. https://www.nd.gov/dhs/services/medicalserv/medicaid/
  6. Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy (RENAAL). N Engl J Med. 2001;345(12):861-869. https://pubmed.ncbi.nlm.nih.gov/11565518/
  7. Whelton PK, Carey RM. The 2017 Clinical Practice Guideline for High Blood Pressure. JAMA. 2017;318(21):2073-2074. https://pubmed.ncbi.nlm.nih.gov/29159416/
  8. CMS. Health Insurance Marketplace Plan Data 2025. Centers for Medicare and Medicaid Services. https://www.cms.gov/cciio/resources/data-resources/marketplace-puf
  9. CMS. Medicare Part D Drug Spending Dashboard. Centers for Medicare and Medicaid Services. https://www.cms.gov/data-research/statistics-trends-and-reports/medicare-part-d-drug-spending-dashboard
  10. FDA. Bioequivalence Studies With Pharmacokinetic Endpoints for Drugs Submitted Under an ANDA. U.S. Food and Drug Administration. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/bioequivalence-studies-pharmacokinetic-endpoints-drugs-submitted-under-anda
  11. FDA. Compounding Laws and Policies. U.S. Food and Drug Administration. https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies
  12. Nahata MC, Morosco RS, Hipple TF. Stability of losartan potassium in two liquid dosage forms. Ann Pharmacother. 1999;33(9):946-949. https://pubmed.ncbi.nlm.nih.gov/10492491/
  13. North Dakota State Board of Pharmacy. Licensed Pharmacy Search. https://www.nodakpharmacy.gov/
  14. North Dakota Century Code Chapter 43-17. Practice of Medicine. https://www.legis.nd.gov/cencode/t43c17.pdf
  15. Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021;384(11):989-1002. https://pubmed.ncbi.nlm.nih.gov/33567185/
  16. Margolis KL, Asche SE, Bergdall AR, et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA. 2013;310(1):46-56. https://pubmed.ncbi.nlm.nih.gov/23821088/
  17. NeedyMeds. Patient Assistance Programs. https://www.needymeds.org/
  18. Merck Patient Assistance Program. https://www.merck.com/patient-assistance-program/
  19. Quinlan SC, Gorse GJ. Tablet splitting: a practical guide for pharmacists. Am J Health Syst Pharm. 2009;66(4):374-379. https://pubmed.ncbi.nlm.nih.gov/19208723/
  20. Palmer BF. Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system. N Engl J Med. 2004;351(6):585-592. https://pubmed.ncbi.nlm.nih.gov/15295051/
  21. Heran BS, Musini VM, Bassett K, Taylor RS, Wright JM. Angiotensin receptor blockers for heart failure. Cochrane Database Syst Rev. 2012;4:CD003040. https://pubmed.ncbi.nlm.nih.gov/22513909/
  22. NABP. .Pharmacy Verified Websites Program. National Association of Boards of Pharmacy. https://nabp.pharmacy/programs/dot-pharmacy/
  23. CMS. Extra Help with Medicare Prescription Drug Plan Costs. Centers for Medicare and Medicaid Services. https://www.cms.gov/medicare/part-d/costs/low-income-subsidy
  24. HRSA. 340B Drug Pricing Program. Health Resources and Services Administration. https://www.hrsa.gov/opa/index.html
  25. Indian Health Service. Pharmacy Program. https://www.ihs.gov/pharmacy/
  26. North Dakota Insurance Department. Consumer Assistance. https://www.nd.gov/ndins/consumers/